Skip to Content

Onivyde

In the US, Onivyde (irinotecan liposomal systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Pancreatic Cancer.

US matches:

Ingredient matches for Onivyde

Irinotecan

Irinotecan hydrochloride trihydrate (a derivative of Irinotecan) is reported as an ingredient of Onivyde in the following countries:

  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide